TYRX, Inc., a leader in the development and commercialization of combination drug-device products, has provided a grant for a live CME webcast hosted by leading physicians entitled, "New Standards of Care for CRMD Antibiotic Protection." The Interactive Web Symposia was presented live November 18 and 19, 2008 by Rabih O. Darouiche, MD and Charles J. Love, MD. The content will remain online for one year.

Dr. Darouiche, VA Distinguished Service Professor, Director, Center for Prostheses Infection, Baylor College of Medicine covered: "Prevention of Device-Related Infections." Dr. Love, Professor of Clinical Medicine, Division of Cardiovascular Medicine, Ohio State University Medical Center and Director, Arrhythmia Device Services and Associate Investigator, Dorothy M. Davis Heart & Lung Research Institute (Columbus, OH), presented: "Current Trends in Implantable Device Infection and Management."

The program is designed to educate physicians, nurses and technologists toaddress the pathogenesis of infections associated with pacemakers; and cardioverter defibrillators; assess the anti-infective efficacy of

potentially preventive approaches; and describe the risks and costs associated with resolving device-related infections. Here is the link:
http://www.naccme.com/program/n-290/

This webcast provided electrophysiologists and cardiac surgeons with valuable tools to help protect their patients, reduce implant infections and save unnecessary hospital costs.

A score of 70 percent or above comprises a passing grade. A documentation of credit will be awarded to participants who successfully complete the exam. Those who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Physicians and nurses will be able to register online and complete the program for credit for one year following the webcast.

This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical
education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(TM).

NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the
American Nurses Credentialing Center's Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour (Provider Number 110-3-E-06). Provider approved by the California Board of Registered Nursing, Provider Number 13255, for 1 contact hour.

About TYRX, Inc.

TYRX, Inc. is a global leader in the development of novel combination drug-device products that address surgical site infections (SSIs) across a
broad range of surgical applications, including general, cardiovascular and cosmetic-surgical markets. TYRX's lead product platform, AIGISRx CRMD (cardiac rhythm management device), is a 510k cleared antimicrobial surgical mesh designed to deliver site specific therapy to prevent SSIs
following CRMD implantation. The combination medical products sector (products incorporating both a drug and a device component) is expected to
be the highest growth segment of the medical products industry, and TYRX is positioned to be an innovative leader in this space.

TYRX, an IS0 9001:2000 and IS0 13485:2003 certified medical device manufacturer, has exclusively licensed product patents and associated technologies from Rutgers, The State University of New Jersey, Baylor College of Medicine and The University of Texas M.D. Anderson CancerCenter. More information may be found at http://www.TYRX.com.